Bespoke Extracts (BSPK) Operating Income Growth (1y) (2015 - 2025)
Bespoke Extracts (BSPK) Operating Income Growth (1y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.42 Bn | 87.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn | 25.63% |
| 3 | Zoetis | 32.68 Bn | 30.74 Bn | 1.62 Bn | -1.30% |
| 4 | Takeda Pharmaceutical | 27.63 Bn | 23.57 Bn | 4.39 Bn | -319.32% |
| 5 | United Therapeutics | 23.16 Bn | 21.01 Bn | 648.10 Mn | -14.89% |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.34 Bn | 18.54 Bn | 1.16 Bn | 97.23% |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn | 719.49% |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn | 21.25% |
| 10 | Bespoke Extracts | 1.12 Mn | 1.11 Mn | 234,175.00 | 79.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 79.47% |
| Jun 30, 2025 | 35.28% |
| Mar 31, 2025 | 18.98% |
| Dec 31, 2024 | 32.39% |
| Sep 30, 2024 | 11.39% |
| Jun 30, 2024 | 46.47% |
| Mar 31, 2024 | 31.70% |
| Dec 31, 2023 | 70.60% |
| Sep 30, 2023 | 73.89% |
| Jun 30, 2023 | 53.81% |
| Mar 31, 2023 | 54.42% |
| Nov 30, 2021 | 66.39% |
| May 31, 2021 | 90.67% |
| Feb 28, 2021 | 4.19% |
| Nov 30, 2020 | 49.29% |
| May 31, 2020 | -899.81% |
| Feb 29, 2020 | 11.72% |
| Nov 30, 2019 | -109.93% |
| Aug 31, 2019 | 85.70% |
| May 31, 2019 | 85.73% |